Osmetech signs distribution agreement with Fisher HealthCare
James White, CEO of Osmetech, said: “We are delighted that Fisher HealthCare has partnered with Osmetech, highlighting the attraction of our eSensor XT-8 platform. We will work closely
Australia-based Telix Pharmaceuticals has agreed to acquire ITM Isotope Technologies Munich in a transaction valued at up to $2.35bn, combining Telix’s operations with ITM’s radioisotope production business and late-stage treatment candidate ITM-11.